- Jul 2018
-
europepmc.org europepmc.org
-
On 2014 Sep 15, Amanda Capes-Davis commented:
The authors use the cell line HEp-2 to look at sensitivity to cisplatin. Please be aware that HEp-2 is cross-contaminated with HeLa, a cervical adenocarcinoma cell line. Results obtained from HEp-2 do not relate to laryngeal carcinoma.
Cell lines can be tested for cross-contamination through consensus methods such as short tandem repeat (STR) profiling. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
On 2014 Sep 15, Amanda Capes-Davis commented:
The authors use the cell line HEp-2 to look at sensitivity to cisplatin. Please be aware that HEp-2 is cross-contaminated with HeLa, a cervical adenocarcinoma cell line. Results obtained from HEp-2 do not relate to laryngeal carcinoma.
Cell lines can be tested for cross-contamination through consensus methods such as short tandem repeat (STR) profiling. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-